Anti-Huntington’s Effect of Butin in 3-Nitropropionic Acid-Treated Rats: Possible Mechanism of Action

被引:0
|
作者
Sultan Alshehri
Fahad A. Al-Abbasi
Mohammed M. Ghoneim
Syed Sarim Imam
Muhammad Afzal
Khalid Saad Alharbi
Muhammad Shahid Nadeem
Nadeem Sayyed
Imran Kazmi
机构
[1] King Saud University,Department of Pharmaceutics, College of Pharmacy
[2] King Abdulaziz University,Department of Biochemistry, Faculty of Science
[3] AlMaarefa University,Department of Pharmacy Practice, College of Pharmacy
[4] Jouf University,Department of Pharmacology, College of Pharmacy
[5] Meril Life Sciences Pvt. Ltd,Clinical Research Department
来源
Neurotoxicity Research | 2022年 / 40卷
关键词
Butin; Neuroprotective; Flavonoids; Mitochondrial dysfunction; Acetylcholinesterase;
D O I
暂无
中图分类号
学科分类号
摘要
Butin has a strong antioxidant plus anti-inflammatory action and it is reported to be protective in oxidative stress-induced mitochondrial dysfunction. Butin has been shown to protect the mouse hippocampus HT22 cells from glutamate-induced neurotoxicity. The current investigation was planned to assess anti-Huntington’s effect of butin in 3-nitropropionic acid-treated rats. A total of 32 Wistar rats (200–240 g) were equally segregated into four groups. Groups I and II were treated with vehicle (0.3 ml/100 g) and groups III and IV received butin 25 and 50 mg/kg for 15 days. Daily 1 h post above oral treatments, 3 ml/kg of normal saline was injected (i.p.) to group I animals and 10 mg/kg of 3-NP was injected (i.p.) to II and IV groups for 15 days. During the experimental schedule, behavioral tests were conducted for animals. On day 15, after behavioral parameters, animals were sacrificed and brains were removed for biochemical tests. Systemic administration of 3-NP induced neurobehavioral deficits which resulted in reduced spontaneous locomotor activity, motor incoordination, learning ability, and memory in the animals. Moreover, 3-NP depleted endogenous antioxidants (GSH, catalase, and SOD), mitochondrial complexes activities (I, II, IV, and MTT assay), elevated LDH, MDA, nitrite, and AchE. Administration of butin significantly improved neurobehavioral impairments, nitrative and oxidative stress, activities of mitochondrial enzyme complex, and reduced AchE levels in rat brain.
引用
收藏
页码:66 / 77
页数:11
相关论文
共 50 条
  • [21] BDNF regulates BIM expression levels in 3-nitropropionic acid-treated cortical neurons
    Almeida, Sandra
    Laco, Mario
    Cunha-Oliveira, Teresa
    Oliveira, Catarina R.
    Rego, A. Cristina
    NEUROBIOLOGY OF DISEASE, 2009, 35 (03) : 448 - 456
  • [22] Ellagic acid prevents 3-nitropropionic acid induced symptoms of Huntington’s disease
    Priya Sharma
    Manish Kumar
    Nitin Bansal
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2021, 394 : 1917 - 1928
  • [23] Metabonomic Characterization of the 3-Nitropropionic Acid Rat Model of Huntington’s Disease
    T. M. Tsang
    J. N. Haselden
    E. Holmes
    Neurochemical Research, 2009, 34 : 1261 - 1271
  • [24] Genetic Modulators of 3-Nitropropionic Acid Neurotoxicity: Implications for Huntington's Disease
    Dietrich, Paula
    Alli, Shanta
    Mulligan, Megan
    Williams, Robert
    Dragatsis, Ioannis
    NEUROTHERAPEUTICS, 2019, 16 (04) : 1358 - 1358
  • [25] Rhes Deletion Is Neuroprotective in the 3-Nitropropionic Acid Model of Huntington's Disease
    Mealer, Robert G.
    Subramaniam, Srinivasa
    Snyder, Solomon H.
    JOURNAL OF NEUROSCIENCE, 2013, 33 (09): : 4206 - 4210
  • [26] Ellagic acid prevents 3-nitropropionic acid induced symptoms of Huntington's disease
    Sharma, Priya
    Kumar, Manish
    Bansal, Nitin
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2021, 394 (09) : 1917 - 1928
  • [27] Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid
    Guyot, MC
    Hantraye, P
    Dolan, R
    Palfi, SM
    Maziere, M
    Brouillet, E
    NEUROSCIENCE, 1997, 79 (01) : 45 - 56
  • [28] Increased vulnerability to 3-nitropropionic acid in an animal model of Huntington's disease
    Bogdanov, MB
    Ferrante, RJ
    Kuemmerle, S
    Klivenyi, P
    Beal, MF
    JOURNAL OF NEUROCHEMISTRY, 1998, 71 (06) : 2642 - 2644
  • [29] Metabonomic Characterization of the 3-Nitropropionic Acid Rat Model of Huntington's Disease
    Tsang, T. M.
    Haselden, J. N.
    Holmes, E.
    NEUROCHEMICAL RESEARCH, 2009, 34 (07) : 1261 - 1271
  • [30] Neuroprotective potency of mangiferin against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats: possible antioxidant and anti-inflammatory mechanisms
    Lum, Pei Teng
    Sekar, Mahendran
    Seow, Lay Jing
    Shaikh, Mohd Farooq
    Arulsamy, Alina
    Retinasamy, Thaarvena
    Gan, Siew Hua
    Gnanaraj, Charles
    Esa, Norhaizan Mohd
    Ramachawolran, Gobinath
    Subramaniyan, Vetriselvan
    Chinni, Suresh V.
    Wu, Yuan Seng
    FRONTIERS IN PHARMACOLOGY, 2023, 14